Weight Loss And Obesity Management Market To Surpass US$ 294.2 Billion By 2027
Obesity is defined by excessive body fat and higher body mass index. The average BMI index for obesity is above 30 (obese). Obesity is one of the most prevalent disease conditions across the world, and it is prevalent in developed, emerging, and undeveloped regions. Increasing incidence of obesity is expected to drive growth of the market during the forecast period. According to World Health Organization (WHO) reports published in 2018, the number of obese individual has tripled since 1975 and nearly 41 million children around the world are obese. Get More Insights (at) https://www.coherentmarketinsights.com/market-insight/weight-loss-and-obesity-management-market-3448
Obesity is defined by excessive body fat and higher body mass index. The average BMI index for obesity is above 30 (obese). Obesity is one of the most prevalent disease conditions across the world, and it is prevalent in developed, emerging, and undeveloped regions.
Increasing incidence of obesity is expected to drive growth of the market during the forecast period. According to World Health Organization (WHO) reports published in 2018, the number of obese individual has tripled since 1975 and nearly 41 million children around the world are obese.
Get More Insights (at) https://www.coherentmarketinsights.com/market-insight/weight-loss-and-obesity-management-market-3448
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
GLOBAL<br />
WEIGHT LOSS & OBESITY<br />
MANAGEMENT MARKET<br />
<strong>Market</strong> Size (2019)<br />
<strong>US$</strong> 170.0 Bn<br />
CAGR (2019-<strong>2027</strong>)<br />
7.1 %<br />
PROMINENT REGIONS<br />
MAJOR DRIVERS<br />
NORTH AMERICA<br />
<strong>Market</strong> Share (2019)<br />
<strong>US$</strong> 77.8 Bn<br />
Increasing research and development<br />
Increasing strategic partnerships<br />
ASIA PACIFIC<br />
SEGMENTATION (SCOPE)<br />
<strong>By</strong> Product & Services<br />
Drugs<br />
Bupropion-naltrexone (Contrave)<br />
Liraglutide (Saxenda)<br />
Lorcaserin (Belviq)<br />
Orlistat (Xenical)<br />
Phentermine-topiramate (Qsymia)<br />
Others<br />
Supplements<br />
Equipment<br />
Fitness Equipment<br />
Surgical Equipment<br />
Services<br />
Consulting Service<br />
Online <strong>Weight</strong> <strong>Loss</strong> Programs<br />
Others<br />
MAJOR DRIVER<br />
Increasing product approvals<br />
<strong>By</strong> Age Group<br />
Children<br />
Adults<br />
Geriatrics<br />
MAJOR DRIVERS<br />
Increasing prevalence of obesity<br />
Increasing adoption of expansion strategies by major players<br />
MAJOR PLAYERS<br />
Novo Nordisk A/S<br />
Takeda Pharmaceutical Company Ltd<br />
Eisai Co.<br />
F. Hoffmann-La Roche Ltd<br />
VIVUS Inc.<br />
Herbalife Ltd.<br />
Apollo Endosurgery (U.S.)<br />
Amer Sports<br />
Brunswick Corporation<br />
Cybex International<br />
Duke Products & Services & Fitness Center<br />
Ethicon Inc.<br />
Equinox, Inc.<br />
Johnson & Johnson Services, Inc.<br />
Kellogg Company<br />
Life Time Fitness Inc.<br />
Medtronic<br />
NutriSystem, Inc.<br />
Coherent <strong>Market</strong> Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve<br />
transformational growth by helping them make Critical business decisions. We are headquartered in India, having office al global<br />
financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are<br />
uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about<br />
operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated<br />
market research reports that help our clients create visionary growth plans to provide traction to their business.
Change language